Pharmaniaga skids on govt plan to focus on Pfizer


A health worker displays the Covid-19 vaccines developed by China's Sinovac. - Xinhua

KUALA LUMPUR: Shares of Pharmaniaga fell to a low of 88.5 sen on Friday after the government said states will begin dispensing more Pfizer-BioNTech vaccines over Sinovac.

Pharmaniaga has the contract to deliver the Sinovac vaccines and the latest statement worried investors as it had plans to expand the output of the China vaccine later.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , Sinovac , Pfizer

Next In Business News

Pursuing the Elixir of growth
The AI finance revolution
Energy crunch singes New Delhi street stalls
A winner in medals
Winners and losers in carbon-priced climate
A time of carbon reckoning
Gulf luxury car profits under siege
Oil & war the big woes
‘Mr Brexit’ made winning�calls amid Iran war
Impact assessment timely for�construction sector

Others Also Read